Sunho Biologics, Inc.
HKSE: 2898.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Feng Zhang
- Employees
- 130
- Headquarters
- Huzhou, China
- IPO year
- 2002
- Market cap
- HK$1.0B
- Website
- https://www.sunho-bio.com.cn
Loading 2898…
Loading profile data…Frequently asked questions about 2898
What does Sunho Biologics, Inc. (2898.HK) do?
Sunho Biologics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics that regulate immune microenvironment by modulating the innate and adaptive immune systems. It offers IAH0968, an antibody-dependent cell mediated cytotoxicity enhanced monoclonal antibody, which is in the Phase II clinic...
Where does 2898.HK trade?
Sunho Biologics, Inc. (2898.HK) trades on the Hong Kong Stock Exchange.
What sector is 2898.HK in?
Sunho Biologics, Inc. (2898.HK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sunho Biologics, Inc.?
Feng Zhang is the chief executive officer of Sunho Biologics, Inc. (2898.HK).
Where is Sunho Biologics, Inc. headquartered?
Sunho Biologics, Inc. is headquartered in China.
Does 2898.HK pay a dividend?
Sunho Biologics, Inc. (2898.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 2898.HK go public?
Sunho Biologics, Inc. (2898.HK) completed its initial public offering in 2002.